Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: clinical trial

Phase II Trials of AR101 with Dupilumab for Peanut Allergy to...

Viaskin Peanut Completes Phase III Part A Study of Toddlers With...

Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate

Aimmune to Submit FDA Application for Peanut OIT Candidate by End...

Milk and Peanut Clinical Trial Advances

Results of Phase III Trial of Aimmune's Peanut OIT Therapy

Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

Follow Us

Your School On Our Map

Put Your School on the Map